250612-42-1|2,2,2-Trifluoroacetic acid compound with 2-((2S,5R,8S,11S)-8-(4-aminobutyl)-11-(3-guanidinopropyl)-5-(4-hydroxybenzyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid (2:1)|BLD Pharm

Startseite/ Inhibitors/Agonists/ Cytoskeleton/ Integrin/2,2,2-Trifluoroacetic acid compound with 2-((2S,5R,8S,11S)-8-(4-aminobutyl)-11-(3-guanidinopropyl)-5-(4-hydroxybenzyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid (2:1)

2,2,2-Trifluoroacetic acid compound with 2-((2S,5R,8S,11S)-8-(4-aminobutyl)-11-(3-guanidinopropyl)-5-(4-hydroxybenzyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid (2:1) *Cold-chain transportation

CAS NO.： 250612-42-1

Größe	Preis	Verkaufsrabatt	Rabatt	Lager-CN	Lager-US	Lager-IND	Lager-EU	Menge

How to Order +86-21-61629022 sales@bldpharm.com tech@bldpharm.com Catalog

The item is temporarily out of stock. Please leave your email address and we will inform you when we have it in stock.

How to Order

PRODUKT INFORMATION

Produktdetails
Sicherheit

Produkt Name :	2,2,2-Trifluoroacetic acid compound with 2-((2S,5R,8S,11S)-8-(4-aminobutyl)-11-(3-guanidinopropyl)-5-(4-hydroxybenzyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid (2:1)
CAS Nr. :	250612-42-1	Molekulargewicht :	847.72
MDL Nr. :	MFCD20134101	Feinheit/Spezifikation :
Molekularformel :	C₃₁H₄₃F₆N₉O₁₂	Lagerung :	Inert atmosphere,2-8°C
Siedepunkt :	No data available

GHS Pictogram :
Signal Word :	Danger	Precautionary Statements :	P260-P264-P270-P273-P280-P301+P312+P330-P304+P312-P305+P351+P338-P314-P337+P313-P391-P501
UN# :	3077	Class :	9
Hazard Statements :	H302-H319-H332-H372-H400	Packing Group :	Ⅲ

2,2,2-Trifluoroacetic acid compound with 2-((2S,5R,8S,11S)-8-(4-aminobutyl)-11-(3-guanidinopropyl)-5-(4-hydroxybenzyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid (2:1) *Cold-chain transportation

PRODUKT INFORMATION

ZUSAMMENHÄNGENDE PRODUKTE

HISTORISCHE AUFZEICHNUNGEN

Kontakt